Pediatrix Medical Group, Inc. (MD) Stock Analysis & Investment Frameworks
Pediatrix Medical Group, Inc. (MD) stock analysis on Invetso. Review Pediatrix Medical Group, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Pediatrix Medical Group, Inc. Company Overview
- Exchange: New York Stock Exchange
- Sector: Healthcare
- Industry: Medical - Care Facilities
- Country: US
Pediatrix Medical Group, Inc. Key Financial Metrics
- Market Cap: $2.44B
- Revenue: $1.91B
- P/E Ratio: 14.76
- ROE: 17.28%
- ROIC: 9.18%
- Dividend Yield: N/A
About Pediatrix Medical Group, Inc.
Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.